CENTER FOR GENETIC ENGINEERING AND BIOTECHNOLOGY

Trials shown by sponsor

Public title	Date of Registration	State
Reactogenicity and Immunogenicity of the pentavalent vaccine DPT-HB+Hib. Schedule 2-4-6 months.	2011-04-29	Registered
NEUVITAL V Study	2011-04-30	Registered
Change in Manufacture Process of Heberbiovac HB vaccine.	2011-04-30	Registered
GrUVen-I Study	2011-05-03	Registered
EGFpeeling I	2011-05-03	Registered
Clinical Trial Heberbiovac HB vaccine Material Reference Batch	2011-05-16	Registered
NASVAC therapeutic vaccine study	2011-05-16	Registered
Heberprovac Study	2011-05-16	Registered
TS-FARMEV Study	2011-05-16	Registered
Gamma IFN in Idiopathic Pulmonary Fibrosis.	2011-05-17	Registered
CERVISEG-300-I Study	2011-05-17	Registered
InMuMyel I Study	2011-05-19	Registered
HeberproGen Study	2011-05-20	Registered
SOFIA Study	2011-05-24	Registered
INJURE Study	2011-07-11	Registered
MAGINC Study	2011-07-12	Registered
Teravac HIV in chronic HIV-1.	2011-08-10	Registered
THERESA-4 Study	2011-10-25	Registered
HeberPAG® in Mycosis Fungoides (MYFIC Study)	2012-06-08	Registered
Quimi-Hib® and Quimi-Hib(AlPO4) vaccines in an accelerated 6-10-14 weeks primary vaccination series	2012-09-12	Registered